What does this research mean for the field?

Combination therapy with ACE inhibitors and AT1 receptor antagonists consistently provides an enhanced anti-proteinuric effect in patients with chronic glomerular disease, though its long-term impact on preventing end-stage renal failure requires further investigation. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

April 1, 2002Journal of Hypertension

Dual angiotensin II blockade: a promise of enhanced renal protection?

View Full Paper

Ask AI

Bookmark

Why the study?

Does combination ACE inhibitor and AT1 receptor antagonist treatment reduce proteinuria in patients with chronic glomerulonephritis?

Population

Patients with diabetic and non-diabetic renal disease, specifically chronic proteinuric glomerular disease…

Comparison

Combination angiotensin-converting enzyme… vs ACE inhibitor monotherapy or AT1 receptor…

Design

Editorial

Authors

HTH. ThurstonUniversity Hospitals of Leicester NHS Trust

Discussion

Member takes

Implication

Combination ACE inhibitor and AT1 receptor antagonist therapy provides an additive anti-proteinuric effect in patients with chronic glomerulonephritis, though large prospective trials are needed to determine if this translates to delayed end-stage renal failure.

Structured PICO

Does combination ACE inhibitor and AT1 receptor antagonist treatment reduce proteinuria in patients with chronic glomerulonephritis?

Population

Patients with diabetic and non-diabetic renal disease, specifically chronic proteinuric glomerular disease or chronic glomerulonephritis

Intervention

Combination angiotensin-converting enzyme (ACE) inhibitor and AT1 receptor antagonist treatment (dual angiotensin II blockade)

Comparator

ACE inhibitor monotherapy or AT1 receptor antagonist monotherapy

Outcome

Reduction in proteinuriasurrogate

Limitations

Use of non-standardized ACE inhibitor treatment not titrated to the maximum dose
Small group sizes in the reviewed studies
Short treatment periods (6-8 weeks)

Cite This Study

H. Thurston (2002) studied this question.

synapsesocial.com/papers/6a12eaa083732aa7db9e8db4 https://doi.org/10.1097/00004872-200204000-00014

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Dual angiotensin II blockade: a promise of enhanced renal protection?

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Topics

Dual angiotensin II blockade: a promise of enhanced renal protection?

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Also Consider

Topics

Also Consider